• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nephroureterectomy for transitional cell carcinoma - the value of pre-operative histology.肾盂输尿管切除术治疗移行细胞癌——术前组织学检查的价值
Ann R Coll Surg Engl. 2008 Jan;90(1):45-50. doi: 10.1308/003588408X242268.
2
Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.经输尿管镜和切除术治疗上尿路尿路上皮癌:160 例连续患者 15 年的综合回顾。
BJU Int. 2012 Dec;110(11):1618-26. doi: 10.1111/j.1464-410X.2012.11066.x. Epub 2012 Mar 28.
3
Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma.腹腔镜肾输尿管切除术治疗上尿路移行细胞癌。
Arch Esp Urol. 2002 Jul-Aug;55(6):595-601.
4
Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.诊断性输尿管肾镜检查与上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发增加有关。
PLoS One. 2015 Nov 10;10(11):e0139976. doi: 10.1371/journal.pone.0139976. eCollection 2015.
5
Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.机器人辅助腹腔镜肾输尿管切除术联合膀胱袖口切除术治疗上尿路尿路上皮癌后的肿瘤学结局
J Urol. 2015 Dec;194(6):1561-6. doi: 10.1016/j.juro.2015.07.081. Epub 2015 Jul 17.
6
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.在上尿路尿路上皮癌患者接受肾输尿管切除术和膀胱袖状切除术治疗中,肿瘤位置与多灶性的影响:无围手术期化疗的同质系列。
BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.
7
Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.上尿路移行细胞癌开放性肾输尿管切除术中内镜下输尿管离断术与正规膀胱袖口状切除术的比较结果
J Urol. 2009 Feb;181(2):532-9. doi: 10.1016/j.juro.2008.10.032. Epub 2008 Dec 13.
8
Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney.对于所有上尿路移行细胞癌病例,肾输尿管切除术是否必要?对侧肾脏正常的个体中上尿路移行细胞癌保守性腔内治疗的长期结果。
Urology. 2001 Aug;58(2):174-8. doi: 10.1016/s0090-4295(01)01109-8.
9
Management of the distal ureter during nephroureterectomy for upper urinary tract transitional cell carcinoma: a review.上尿路移行细胞癌根治性肾输尿管切除术时远端输尿管的处理:综述
Urol Int. 2010;85(3):249-56. doi: 10.1159/000302715. Epub 2010 Mar 24.
10
Hand-assisted laparoscopic nephroureterectomy versus open nephroureterectomy for the treatment of transitional-cell carcinoma of the upper urinary tract.手辅助腹腔镜肾输尿管切除术与开放性肾输尿管切除术治疗上尿路移行细胞癌的对比
J Endourol. 2001 May;15(4):391-5; discussion 397. doi: 10.1089/089277901300189402.

引用本文的文献

1
Impact of Adjuvant Gemcitabine Containing Chemotherapy Following Radical Nephroureterectomy for Patients with Upper Tract Urothelial Carcinoma: Results from a Propensity-Score Matched Cohort Study.根治性肾输尿管切除术后辅助吉西他滨化疗对上尿路尿路上皮癌患者的影响:倾向评分匹配队列研究结果
Bladder Cancer. 2023 Sep 25;9(3):217-226. doi: 10.3233/BLC-230041. eCollection 2023.
2
Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades.诊断上尿路尿路上皮癌:过去二十年诊断性输尿管镜检查作用及新进展综述
Asian J Urol. 2024 Apr;11(2):242-252. doi: 10.1016/j.ajur.2022.08.003. Epub 2022 Sep 23.
3
Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract.上尿路尿路上皮癌的当代问题
Adv Anat Pathol. 2024 Mar 1;31(2):80-87. doi: 10.1097/PAP.0000000000000421. Epub 2023 Nov 27.
4
Decreased Preoperative Serum AGR as a Diagnostic Marker of Poor Prognosis after Radical Surgery of Upper Urinary Tract and Bladder Cancers from a Pooled Analysis of 9,002 Patients.术前血清 AGR 降低可作为上尿路上皮癌和膀胱癌根治性手术后不良预后的诊断标志物:一项纳入 9002 例患者的汇总分析。
Dis Markers. 2022 Sep 5;2022:6575605. doi: 10.1155/2022/6575605. eCollection 2022.
5
Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma.治疗前血清MMP - 7水平升高与上尿路尿路上皮癌转移的存在及不良生存相关。
Biomedicines. 2022 Mar 17;10(3):698. doi: 10.3390/biomedicines10030698.
6
Biomarker-Oriented Therapy in Bladder and Renal Cancer.膀胱癌和肾癌的生物标志物导向治疗。
Int J Mol Sci. 2021 Mar 11;22(6):2832. doi: 10.3390/ijms22062832.
7
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.在上尿路尿路上皮癌中的辅助化疗(POUT 试验):一项 3 期、开放标签、随机对照试验。
Lancet. 2020 Apr 18;395(10232):1268-1277. doi: 10.1016/S0140-6736(20)30415-3. Epub 2020 Mar 5.
8
Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma.2018 年斯德哥尔摩上尿路尿路上皮癌咨询会议:上尿路尿路上皮癌的诊断要点。
World J Urol. 2019 Nov;37(11):2271-2278. doi: 10.1007/s00345-019-02732-8. Epub 2019 Mar 26.
9
The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.在上尿路尿路上皮癌行根治性肾输尿管切除术之前行诊断性输尿管镜检查与膀胱内复发率升高无关。
World J Surg Oncol. 2018 Jul 9;16(1):135. doi: 10.1186/s12957-018-1411-9.
10
Robotic nephrectomy for central renal tumors with intraoperative evaluation of tumor histology.用于中央型肾肿瘤的机器人肾切除术及术中肿瘤组织学评估
J Robot Surg. 2016 Sep;10(3):261-5. doi: 10.1007/s11701-016-0596-6. Epub 2016 May 4.

本文引用的文献

1
Current practice patterns in urologic management of upper-tract transitional-cell carcinoma.上尿路移行细胞癌泌尿外科管理中的当前实践模式
J Endourol. 2005 Apr;19(3):366-71. doi: 10.1089/end.2005.19.366.
2
A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.膀胱与上尿路移行细胞癌的病理学比较。
BJU Int. 2005 Apr;95(6):791-3. doi: 10.1111/j.1464-410X.2005.05402.x.
3
Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?腹腔镜下肾输尿管切除术治疗上尿路移行细胞癌:它比开放手术更好吗?
Eur Urol. 2004 Dec;46(6):690-7. doi: 10.1016/j.eururo.2004.08.006.
4
Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma.输尿管镜检查表现与上尿路移行细胞癌组织学分级的相关性
Urology. 2004 Apr;63(4):647-50; discussion 650. doi: 10.1016/j.urology.2003.10.076.
5
Ureteroscopic management of upper tract transitional cell carcinoma.
Urol Clin North Am. 2004 Feb;31(1):115-28. doi: 10.1016/S0094-0143(03)00099-5.
6
Role of ureteroscopic biopsy in the management of upper urinary tract malignancy.输尿管镜活检在上尿路恶性肿瘤管理中的作用。
Int J Urol. 2003 Dec;10(12):627-30. doi: 10.1046/j.1442-2042.2003.00721.x.
7
Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.上尿路移行细胞癌的内镜治疗:长期经验
Cancer. 2003 Jul 1;98(1):55-60. doi: 10.1002/cncr.11446.
8
Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment.
Urology. 2003 Jun;61(6):1146-50. doi: 10.1016/s0090-4295(03)00026-8.
9
Fibroepithelial polyps of the urinary tract.泌尿道纤维上皮性息肉
Abdom Imaging. 2002 Mar-Apr;27(2):217-21. doi: 10.1007/s00261-001-0066-z.
10
Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma.计算机断层扫描在上尿路尿路上皮癌术前分期中的局限性。
Urology. 2000 Dec 20;56(6):930-4. doi: 10.1016/s0090-4295(00)00800-1.

肾盂输尿管切除术治疗移行细胞癌——术前组织学检查的价值

Nephroureterectomy for transitional cell carcinoma - the value of pre-operative histology.

作者信息

Chitale Sudhanshu, Mbakada Rashidi, Irving Stuart, Burgess Neil

机构信息

Department of Urology, Norfolk & Norwich University Hospital NHS Trust, Norwich, UK.

出版信息

Ann R Coll Surg Engl. 2008 Jan;90(1):45-50. doi: 10.1308/003588408X242268.

DOI:10.1308/003588408X242268
PMID:18201500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2216716/
Abstract

INTRODUCTION

Nephroureterectomy with excision of a cuff of bladder remains the standard for managing upper tract transitional cell carcinoma (TCC). Increasing use of diagnostic upper tract endoscopy has underlined the importance of obtaining a pre-operative histological diagnosis in order to avoid under-treating high-grade or multifocal disease and over-treating low-grade disease, which could, in selected cases, be managed conservatively. We review nephroureterectomy at our institution over a 10-year period with particular reference to a pre-operative histological diagnosis.

PATIENTS AND METHODS

Nephroureterectomy was performed in 113 patients from February 1994 to February 2004. Of these cases, 58 were for upper tract TCC and 50 of these 58 had intravenous urography (IVU): 9 had only IVU, 28 had an additional CT scan, 5 had an additional ultrasonography and 8 had additional CT + ultrasonography for pre-operative work-up. Thirty-four of the 58 cases had retrograde pyelography. Nineteen (32.7%) of the 58 cases had a pre-operative ureteroscopy (URS) and biopsy; 14 of these had rigid URS for tumours in the lower (11) and middle (3) thirds of the ureter and 5 had flexible URS for pelvicalyceal tumours by an experienced endourologist. Thirty-one (53%) of the 58 tumours were within the pelvicalyceal system and 27 within the ureter (upper, 5; middle, 3; lower, 19). Forty-eight patients underwent a total nephroureterectomy: 40 had a two incision approach and 8 had an endoscopic resection of the lower ureter. Five of the 58 cases had a sub-total nephroureterectomy and 5 a laparoscopic nephroureterectomy with open excision of lower ureter.

RESULTS

Nineteen (32.7%) of the 58 patients had a pre-operative histological diagnosis - 17 G2pTa, 1 G1pTa, and 1 G2pT1. Fourteen (74%) biopsies matched the final postoperative histology, but 1 was down-staged, 3 up-staged and 1 up-graded compared to the original histology. Five (12.8%) of 39 patients without pre-operative histology had no TCC in the final surgical specimen: 4 (10.25%) had benign pathology such as capillary haemangioma, urothelial cysts and reactive urothelial changes while one had renal cell carcinoma (RCC).

CONCLUSIONS

This study underlines the importance of obtaining a pre-operative histological diagnosis in cases with presumed upper tract TCC. Failure to do so can result in unnecessary ablative surgery for benign disease. Such an approach can also help identify multifocality and grade of disease so that treatment of upper tract TCC can be tailored more appropriately with ablative surgery for high-grade or multifocal disease and conservative (endoscopic) therapy for low-grade disease in selected cases. Patients with suspected TCC of the upper tract should be managed at centres where facilities for the comprehensive evaluation of such tumours exist.

摘要

引言

切除一段膀胱袖口状组织的肾输尿管切除术仍是治疗上尿路移行细胞癌(TCC)的标准方法。诊断性上尿路内窥镜检查的使用日益增加,凸显了获得术前组织学诊断的重要性,以避免对高级别或多灶性疾病治疗不足以及对低级别疾病过度治疗,在某些情况下,低级别疾病可采用保守治疗。我们回顾了本机构10年间的肾输尿管切除术,特别关注术前组织学诊断。

患者与方法

1994年2月至2004年2月期间,113例患者接受了肾输尿管切除术。其中,58例为上尿路TCC,这58例中有50例进行了静脉肾盂造影(IVU):9例仅做了IVU,28例额外进行了CT扫描,5例额外进行了超声检查,8例额外进行了CT +超声检查以进行术前评估。58例中有34例进行了逆行肾盂造影。58例中有19例(32.7%)进行了术前输尿管镜检查(URS)及活检;其中14例由经验丰富的腔内泌尿外科医生对输尿管下三分之一(11例)和中三分之一(3例)的肿瘤进行了硬性URS,5例对肾盂肿瘤进行了软性URS。58例肿瘤中有31例(53%)位于肾盂系统内,27例位于输尿管(上段5例;中段3例;下段19例)。48例患者接受了根治性肾输尿管切除术:40例采用两切口入路,8例采用输尿管下段内镜切除术。58例中有5例进行了次全肾输尿管切除术,5例进行了腹腔镜肾输尿管切除术并开放切除输尿管下段。

结果

58例患者中有19例(32.7%)获得了术前组织学诊断——17例为G2pTa,1例为G1pTa,1例为G2pT1。14例(74%)活检结果与最终术后组织学相符,但与原始组织学相比,1例分级降低,3例分级升高,1例升级。39例未进行术前组织学检查的患者中有5例(12.8%)最终手术标本中未发现TCC:4例(10.25%)有良性病变,如毛细血管瘤、尿路上皮囊肿和反应性尿路上皮改变,1例为肾细胞癌(RCC)。

结论

本研究强调了对疑似上尿路TCC病例进行术前组织学诊断的重要性。未进行术前组织学诊断可能导致对良性疾病进行不必要的切除手术。这种方法还可以帮助确定疾病的多灶性和分级,以便对上尿路TCC进行更合适的治疗,对于高级别或多灶性疾病采用切除手术,在某些情况下,对于低级别疾病采用保守(内镜)治疗。疑似上尿路TCC的患者应在具备全面评估此类肿瘤设施的中心进行治疗。